We hypothesized that i) a more precise diagnosis of hyperandrogenemia would rule out the falsely elevated androgens that resulted from inaccurate immunoassays, avoiding overdiagnoses of PCOS; ii) the use of serum AMH concentrations for defining PCOM would increase the proportion of women fulfilling such diagnostic criteria. This evidence concerns the gene AMH and polycystic ovary syndrome.